The l-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus

Amino Acids

Volumn 47, Issue 9, 2015, Pages 1865-1874

  Carmann, Christina ^a   Lilienthal, Eggert ^a   Weigt Usinger, Katharina ^a   Schmidt Choudhury, Anjona ^b   Hörster, Irina ^a   Kayacelebi, Arslan Arinc ^c   Beckmann, Bibiana ^c   Chobanyan Jürgens, Kristine ^c   Tsikas, Dimitrios ^c   Lücke, Thomas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Asymmetric dimethylarginine; Blood; Carbonic anhydrase; Diabetes; Homoarginine; Kidney; Nitrite; Urine

Indexed keywords

ARGININE; CARBONATE DEHYDRATASE; CREATININE; DIMETHYLAMINE; HEMOGLOBIN A1C; HOMOARGININE; INSULIN; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE;

ADOLESCENT; AGE; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY TUBULE ABSORPTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINARY EXCRETION; ADULT; BLOOD; CLINICAL TRIAL; ENZYMOLOGY; KIDNEY; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CARBONIC ANHYDRASES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HOMOARGININE; HUMANS; KIDNEY; LIPID PEROXIDATION; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PROSPECTIVE STUDIES;

EID: 84940461553     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2027-9     Document Type: Article

References (60)

1. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A (2009) Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297:H2068-H2074
2. Al-Agha AE, Ocheltree A, Hakeem A (2013) Occurrence of microalbuminuria among children and adolescents with insulin-dependent diabetes mellitus. Saudi J Kidney Dis Transpl 24:1180-1188
3. Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB (2007) Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metab 92:1881-1885
4. Böger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "l-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 134:2842-2847
5. Böger RH (2006) Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38:126-136
6. Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS (2009) Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119:1592-1600
7. Böhmer A, Groβkopf H, Jordan J, Tsikas D (2012) Human hemoglobin does not contain asymmetric dimethylarginine (ADMA). Nitric Oxide 27:72-74
8. Brooks ER, Langman CB, Wang S, Price HE, Hodges AL, Darling L, Yang AZ, Smith FA (2009) Methylated arginine derivatives in children and adolescents with chronic kidney disease. Pediatr Nephrol 24:129-134
9. Cerami A, Stevens VJ, Monnier VM (1979) Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism 28:431-437
10. Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T (2012a) Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II. Amino Acids 43:805-811
11. Chobanyan-Jürgens K, Schwarz A, Böhmer A, Beckmann B, Gutzki FM, Michaelsen JT, Stichtenoth DO, Tsikas D (2012b) Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 26:126-131
12. Cighetti G, Fermo I, Aman CS, Ferraroni M, Secchi A, Fiorina P, Paroni R (2009) Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress. Free Radic Biol Med 47:307-311
13. Davids M, van Hell AJ, Visser M, Nijveldt RJ, van Leeuwen PA, Teerlink T (2012) Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am J Physiol Heart Circ Physiol 302:H1762-H1770
14. Dreissigacker U, Suchy MT, Maassen N, Tsikas D (2010) Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clin Biochem 43:159-167
15. Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G (2008) Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology 149:3148-3157
16. GłowiÅska-Olszewska B, LuczyÅski W, JabłoÅska J, Otocka A, Florys B, Bossowski A (2010) Asymmetric dimethylarginine (ADMA) in children with diabetes type 1. Pediatr Endocrinol Diabetes Metab 16:137-141
17. Grosskopf H, Böhmer A, Tsikas D (2012) Letter to the editor: "Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine". Am J Physiol Heart Circ Physiol 303:H751-H752
18. Hasanoʇlu A, Okur I, Oren AC, Biberoʇlu G, Oktar S, Eminoʇlu FT, Tümer L (2011) The levels of asymmetric dimethylarginine, homocysteine and carotid intima-media thickness in hypercholesterolemic children. Turk J Pediatr 53:522-527
19. Heilman K, Zilmer M, Kool P, Tillmann V (2009) Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes. Scand J Clin Lab Invest 69:85-91
20. Horowitz JD, Heresztyn T (2007) An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B 851:42-50
21. Huemer M, Simma B, Mayr D, Mühl A, Rami B, Schober E, Ulmer H, Zanier U, Bodamer OA (2011) Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children. J Pediatr 158:602-606
22. Jehlicka P, Stozický F, Mayer O, Varvarovská J, Racek J, Trefil L, Siala K (2009) Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. Physiol Res 58:179-184
23. Kanzelmeyer N, Tsikas D, Chobanyan-Jürgens K, Beckmann B, Vaske B, llsinger S, Das AM, Lücke T (2012) Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria. Amino Acids 42:1765-1772
24. Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D (2014) GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 46: 2205-2217
25. Keimer R, Stutzer FK, Tsikas D, Troost R, Gutzki FM, Frölich JC (2003) Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study. J Cardiovasc Pharmacol 41:284-292
26. Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H, Fliser D (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109:172-177
27. Krebs A, Doerfer J, Grünert SC, Wöhrl J, Stier B, Schmidt-Trucksäss A, Lichte K, Winkler K, Grulich-Henn J, Holder M, Schwab KO (2015) Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastatin. J Pediatr Endocrinol Metab 28:147-152
28. Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P (2009) Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 31:747-752
29. Lücke T, Tsikas D, Kanzelmeyer N, Vaske B, Das AM (2006) Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia. Metabolism 55:1599-1603
30. Lücke T, Kanzelmeyer N, Kemper MJ, Tsikas D, Das AM (2007) Developmental changes in the l-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age. Clin Chem Lab Med 45:1525-1530
31. Lücke T, Kanzelmeyer N, Chobanyan K, Tsikas D, Franke D, Kemper MJ, Ehrich JH, Das AM (2008) Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 23:734-740
32. Marcovecchio ML, Widmer B, Dunger DB, Dalton RN (2008) Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes. Clin Sci (Lond) 115:361-369
33. Marcovecchio ML, Widmer B, Turner C, Dunger DB, Dalton RN (2011) Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c). Diabet Med 28:685-691
34. Marletta MA (1993) Nitric oxide synthase: function and mechanism. Adv Exp Med Biol 338:281-284
35. Martens-Lobenhoffer J, Bode-Böger SM (2012) Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J Chromatogr B 904:140-143
36. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967-975
37. Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M (2005) Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr 117:816-820
38. Modun D, Krnic M, Vukovic J, Kokic V, Kukoc-Modun L, Tsikas D, Dujic Z (2012) Plasma nitrite concentration decreases after hyperoxia-induced oxidative stress in healthy humans. Clin Physiol Funct Imaging 32:404-408
39. Moncada S, Higgs EA (2006) The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147:193-201
40. Önder A, Aycan Z, Koca C, Ergin M, Çetinkaya S, Aʇladioʇlu SY, Peltek Kendirci HN, Baş VN (2014) Evaluation of asymmetric dimethylarginine (ADMA) levels in children with growth hormone deficiency. J Clin Res Pediatr Endocrinol 6:22-27
41. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
42. Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A (2015) Homoarginine in the renal and cardiovascular systems. Amino Acids. doi: 10.1007/s00726-015-1993-2
43. Sanli C, Oguz D, Olgunturk R, Tunaoglu FS, Kula S, Pasaoglu H, Gulbahar O, Cevik A (2012) Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease. Pediatr Cardiol 33:1323-1331
44. Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, van Leeuwen PA (2006) The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26:203-228
45. Sladowska-Kozłowska J, Litwin M, Niemirska A, Płudowski P, Wierzbicka A, Skorupa E, Wawer ZT, Janas R (2012) Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy. Pediatr Nephrol 27:1943-1951
46. Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH (2004) Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 27:765-769
47. Tran CT, Leiper JM, Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4:33-40
48. Tsikas D (2000) Simultaneous derivatization and quantification of the nitric oxide by gas chromatography/mass spectrometry. Anal Chem 72:4064-4072
49. Tsikas D (2008) Determination of asymmetric dimethylarginine in biological fluids: a paradigm for a successful analytical story. Curr Opin Clin Nutr Metab Care 11:592-600
50. Tsikas D (2015) Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric Oxide 45:1-3
51. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frölich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798:87-99
52. Tsikas D, Thum T, Becker T, Pham VV, Chobanyan K, Mitschke A, Beckmann B, Gutzki FM, Bauersachs J, Stichtenoth DO (2007) Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. J Chromatogr B 851:229-239
53. Tsikas D, Wolf A, Mitschke A, Gutzki FM, Will W, Bader M (2010a) GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays. J Chromatogr B 878:2582-2592
54. Tsikas D, Schwarz A, Stichtenoth DO (2010b) Simultaneous measurement of [15N]nitrate and [15N]nitrite enrichment and concentration in urine by gas chromatography mass spectrometry as pentafluorobenzyl derivatives. Anal Chem 82:2585-2587
55. Tsikas D, Niemann J, Flentje M, Schwarz A, Tossios P (2014) N-Acetylcysteine (NAC) inhibits renal nitrite and nitrate reabsorption in healthy subjects and in patients undergoing cardiac surgery: risk of nitric oxide (NO) bioavailability loss by NAC? Int J Cardiol 177:30-33
56. Tsikas D, Pham VV, Suchy MT, van de Reeb MA, Huisman MV, Frölich JC, Princen HMG, on behalf of the DALI study (2015) No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study. Pharmacol Res 94:1-8
57. Vallance P (2001) Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 358:2096-2097
58. Vallance P, Leiper (2004) Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24:1023-1030
59. Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575
60. Wang S, Vicente FB, Miller A, Brooks ER, Price HE, Smith FA (2007) Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 45:1305-1312